Stem Cell :: Not all embryonic stem cell lines are created equal

When it comes to generating neurons, researchers have found that not all embryonic stem (ES) cell lines are equal. In comparing neurons generated from two NIH-approved embryonic stem cell lines, scientists have uncovered significant differences in the mature, functioning neurons generated from each line.

Beer :: Beer is beverage of choice for most adult binge drinkers

Beer is the beverage of choice for most adult binge drinkers, according to a new study from the Centers for Disease Control and Prevention. The beverage preferences of excessive drinkers are important to public health because binge drinking is a common problem in the United States and because binge drinkers ? and those around them ? are especially vulnerable to alcohol-related problems, said lead study author Timothy Naimi, M.D.

Stroke :: Promote stroke awareness in Hispanic Community

The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), announced the launch of a new community education program, which broadens the Institute?s national stroke education campaign Know Stroke. Know the Signs. Act in Time. to promote stroke awareness among Hispanics in the United States.

COPD :: GSK receives decision from FDA on Advair 500/50 for COPD

GlaxoSmithKline announced that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the supplemental drug application for the 500/50 strength of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in the treatment of patients with chronic obstructive pulmonary disease (COPD).

HIV :: GSK gives consent for generic version of HIV/AIDS medicine for use in Rwanda

As part of its broad commitment to improving access to medicines, GlaxoSmithKline announced it has given consent through Canada?s Access to Medicines Regime to enable a Canadian company (Apotex) to manufacture a generic fixed dose combination (FDC) antiretroviral (ARV), containing two molecules over which GSK has patent rights (zidovudine and lamivudine) for the treatment of HIV/AIDS in Rwanda.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack